
Yes — California nurse practitioners may prescribe semaglutide when it is within their education, training, competence, and applicable prescribing authority. Semaglutide is treated here as not DEA-controlled, so California controlled-substance requirements such as DEA registration and CURES review are not the key issue for this medication.
For NPs practicing under standardized procedures, drug furnishing or ordering must be consistent with educational preparation or clinical competence and covered by the applicable standardized procedures or protocols.1 Qualifying NPs under California’s 103/104 pathways may prescribe pharmacological agents without standardized procedures when those statutory pathways apply.2
NPs must also follow ordinary prescription-drug, facility, payer, and pharmacy requirements. This answer does not address compounding, shortage, weight-loss-program, telehealth, payer, or facility policy requirements.